Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B

References

• Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50:204–210.
   PubMed Web of Science ®Google Scholar
• Carvalhana S, Leitao J, Alves AC, et al. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound. Liver Int. 2014;34:e111–e117.
   PubMed Web of Science ®Google Scholar
• Minakari M, Molaei M, Shalmani HM, et al. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur J Gastroenterol Hepatol. 2009;21:512–516.
   PubMed Web of Science ®Google Scholar
• Wang MM, Wang GS, Shen F, et al. Hepatic steatosis is highly prevalent in Hepatitis B patients and negatively associated with virological factors. Dig Dis Sci. 2014;59:2571–2579.
   PubMed Web of Science ®Google Scholar
• Jin X, Chen YP, Yang YD, et al. Association between Hepatic Steatosis and Entecavir treatment failure in Chinese patients with chronic Hepatitis B. PLoS One. 2012;7:e34198. doi: 10.1371/journal.pone.0034198.
   Web of Science ®Google Scholar
• Tobkes AI, Nord HJ. Liver biopsy: review of methodology and complications. Dig Dis. 1995;13:267–2674.
   PubMed Web of Science ®Google Scholar
• Wai CT, Tan LHC, Kaur M, et al. Pitfalls in interpreting liver biopsy results: the story of the blind men and the elephant. Liver Transpl. 2002;8:1200–1201.
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.
   PubMed Web of Science ®Google Scholar
• Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433–445.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Thomas EL, Bell JD, et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476–483.
   PubMed Web of Science ®Google Scholar
• Hepburn MJ, Vos JA, Fillman EP, et al. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol. 2005;5:14.
   PubMed Web of Science ®Google Scholar
• Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009;51:1061–1067.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–1657.
   PubMed Web of Science ®Google Scholar
• Sasso M, Tengher-Barna I, Ziol M, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat. 2012;19:244–253.
   PubMed Web of Science ®Google Scholar
• Chon YE, Jung KS, Kim SU, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int. 2014;34:102–109.
   PubMed Web of Science ®Google Scholar
• Myers RP, Pollett A, Kirsch R, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012;32:902–910.
   PubMed Web of Science ®Google Scholar
• Masaki K, Takaki S, Hyogo H, et al. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol Res. 2013;43:1182–1189.
   PubMed Web of Science ®Google Scholar
• Shen F, Zheng RD, Mi YQ, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol. 2014;20:4702–4711.
   PubMed Web of Science ®Google Scholar
• Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2014;29:1470–1476.
   PubMed Web of Science ®Google Scholar
• de Ledinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Rev Med Devices. 2010;7:811–823.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Rosenberg W, Parkes J, et al. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol. 2010;10:103.
   PubMed Web of Science ®Google Scholar
• Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36:1825–1835.
   PubMed Web of Science ®Google Scholar
• Yajima Y, Ohta K, Narui T, et al. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med. 1983;139:43–50.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Bioulac-Sage P, Callard P, et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994;20:15–20.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321.
   PubMed Web of Science ®Google Scholar
• Mi YQ, Shi QY, Xu L, et al. Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using fibroscan((R)): validation in chronic hepatitis B. Dig Dis Sci. 2015;60:243–251.
   PubMed Web of Science ®Google Scholar
• de Ledinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911–918.
   PubMed Web of Science ®Google Scholar